vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and FARMERS NATIONAL BANC CORP (FMNB). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $71.5M, roughly 1.2× FARMERS NATIONAL BANC CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 20.5%, a 2.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 3.2%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.2%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
FDMT vs FMNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $71.5M |
| Net Profit | $19.4M | $14.6M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 24.8% |
| Net Margin | 22.8% | 20.5% |
| Revenue YoY | 8508900.0% | 3.2% |
| Net Profit YoY | 139.1% | 1.7% |
| EPS (diluted) | $0.43 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $71.5M | ||
| Q3 25 | $90.0K | $70.8M | ||
| Q2 25 | $15.0K | $69.8M | ||
| Q1 25 | $14.0K | $67.8M | ||
| Q4 24 | $1.0K | $69.3M | ||
| Q3 24 | $3.0K | $70.3M | ||
| Q2 24 | $5.0K | $66.5M | ||
| Q1 24 | $28.0K | $63.4M |
| Q4 25 | $19.4M | $14.6M | ||
| Q3 25 | $-56.9M | $12.5M | ||
| Q2 25 | $-54.7M | $13.9M | ||
| Q1 25 | $-48.0M | $13.6M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $-43.8M | $8.5M | ||
| Q2 24 | $-35.0M | $11.8M | ||
| Q1 24 | $-32.4M | $11.2M |
| Q4 25 | 17.3% | 24.8% | ||
| Q3 25 | -67983.3% | 20.7% | ||
| Q2 25 | -396373.3% | 23.4% | ||
| Q1 25 | -383007.1% | 24.1% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | -1704400.0% | 14.4% | ||
| Q2 24 | -849120.0% | 21.3% | ||
| Q1 24 | -136200.0% | 21.2% |
| Q4 25 | 22.8% | 20.5% | ||
| Q3 25 | -63195.6% | 17.6% | ||
| Q2 25 | -364386.7% | 19.9% | ||
| Q1 25 | -342657.1% | 20.0% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | -1461433.3% | 12.1% | ||
| Q2 24 | -699060.0% | 17.7% | ||
| Q1 24 | -115717.9% | 17.7% |
| Q4 25 | $0.43 | $0.39 | ||
| Q3 25 | $-1.01 | $0.33 | ||
| Q2 25 | $-0.98 | $0.37 | ||
| Q1 25 | $-0.86 | $0.36 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | $-0.79 | $0.23 | ||
| Q2 24 | $-0.63 | $0.31 | ||
| Q1 24 | $-0.66 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | — |
| Total DebtLower is stronger | — | $86.7M |
| Stockholders' EquityBook value | $505.7M | $485.7M |
| Total Assets | $566.7M | $5.2B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | — | ||
| Q3 25 | $305.1M | — | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | — | ||
| Q3 24 | $501.9M | — | ||
| Q2 24 | $541.9M | — | ||
| Q1 24 | $525.9M | — |
| Q4 25 | — | $86.7M | ||
| Q3 25 | — | $86.6M | ||
| Q2 25 | — | $86.4M | ||
| Q1 25 | — | $86.3M | ||
| Q4 24 | — | $86.2M | ||
| Q3 24 | — | $86.0M | ||
| Q2 24 | — | $88.9M | ||
| Q1 24 | — | $88.8M |
| Q4 25 | $505.7M | $485.7M | ||
| Q3 25 | $369.0M | $465.9M | ||
| Q2 25 | $420.9M | $437.7M | ||
| Q1 25 | $469.7M | $429.1M | ||
| Q4 24 | $510.6M | $406.0M | ||
| Q3 24 | $552.9M | $439.7M | ||
| Q2 24 | $588.3M | $396.7M | ||
| Q1 24 | $600.6M | $397.0M |
| Q4 25 | $566.7M | $5.2B | ||
| Q3 25 | $424.0M | $5.2B | ||
| Q2 25 | $473.6M | $5.2B | ||
| Q1 25 | $515.7M | $5.2B | ||
| Q4 24 | $560.4M | $5.1B | ||
| Q3 24 | $604.0M | $5.2B | ||
| Q2 24 | $620.1M | $5.2B | ||
| Q1 24 | $629.9M | $5.1B |
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $60.0M |
| Free Cash FlowOCF − Capex | $28.5M | $52.2M |
| FCF MarginFCF / Revenue | 33.5% | 73.0% |
| Capex IntensityCapex / Revenue | 0.1% | 11.0% |
| Cash ConversionOCF / Net Profit | 1.47× | 4.10× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $85.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $60.0M | ||
| Q3 25 | $-46.5M | $10.7M | ||
| Q2 25 | $-43.4M | $14.0M | ||
| Q1 25 | $-47.8M | $15.7M | ||
| Q4 24 | $-134.6M | $66.6M | ||
| Q3 24 | $-29.4M | $23.9M | ||
| Q2 24 | $-30.2M | $16.6M | ||
| Q1 24 | $-29.1M | $13.7M |
| Q4 25 | $28.5M | $52.2M | ||
| Q3 25 | $-46.6M | $9.0M | ||
| Q2 25 | $-43.4M | $12.4M | ||
| Q1 25 | $-48.4M | $12.2M | ||
| Q4 24 | $-138.4M | $54.9M | ||
| Q3 24 | $-31.2M | $20.4M | ||
| Q2 24 | $-30.6M | $14.4M | ||
| Q1 24 | $-29.8M | $12.2M |
| Q4 25 | 33.5% | 73.0% | ||
| Q3 25 | -51765.6% | 12.8% | ||
| Q2 25 | -289620.0% | 17.8% | ||
| Q1 25 | -345635.7% | 18.0% | ||
| Q4 24 | -13837100.0% | 79.2% | ||
| Q3 24 | -1038966.7% | 29.1% | ||
| Q2 24 | -611840.0% | 21.6% | ||
| Q1 24 | -106421.4% | 19.2% |
| Q4 25 | 0.1% | 11.0% | ||
| Q3 25 | 101.1% | 2.4% | ||
| Q2 25 | 440.0% | 2.3% | ||
| Q1 25 | 4507.1% | 5.2% | ||
| Q4 24 | 378600.0% | 16.9% | ||
| Q3 24 | 59266.7% | 4.9% | ||
| Q2 24 | 6980.0% | 3.3% | ||
| Q1 24 | 2535.7% | 2.4% |
| Q4 25 | 1.47× | 4.10× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 4.63× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 1.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
